Back
Madrigal Pharmaceuticals Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
MDGL
Madrigal Pharmaceuticals
Last Price:
$310.66
Seasonality Move:
15.43%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--hereMadrigal Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 29.7% based on the past 17 years of stock performance.
-
Madrigal Pharmaceuticals has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%
-
Is Madrigal Pharmaceuticals Stock Undervalued?The current Madrigal Pharmaceuticals [MDGL] share price is $310.87. The Score for MDGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Madrigal Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 29.7% based on the past 17 years of stock performance.
Madrigal Pharmaceuticals Stock Rating
Sell
50
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals overpriced?
-
Madrigal Pharmaceuticals has risen higher in 8 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.06%
Madrigal Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
madrigalpharma.com
52-Week Data
52-Week High:
368.29
52-Week Low:
168.25
Prediction Charts
Market Cap:
6.8B
Price in USD:
310.87
Volume:
194.6K
Beta:
1.05
Technical Analysis
SMA50:
290.91
SMA100:
264.17
SMA200:
257.50
52-Wk Change:
32.25%
Stock Predictions
-
Is Madrigal Pharmaceuticals stock public?Yes, Madrigal Pharmaceuticals is a publicly traded company.
-
What is the Madrigal Pharmaceuticals stock quote today?The Madrigal Pharmaceuticals stock price is 310.87 USD today.
-
How to buy Madrigal Pharmaceuticals stock online?You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-4 | 320.79 | 318.48 | 328.17 | 316.18 |
| Dec-5 | 320.06 | 313.05 | 321.14 | 309.00 |
| Dec-6 | 310.96 | 320.84 | 321.99 | 310.96 |
| Dec-9 | 319.19 | 318.44 | 324.24 | 308.55 |
| Dec-10 | 321.31 | 312.77 | 323.75 | 311.57 |
| Dec-11 | 315.87 | 306.55 | 315.87 | 306.00 |
| Dec-12 | 306.21 | 302.47 | 311.77 | 302.47 |
| Dec-13 | 301.12 | 304.50 | 308.65 | 295.02 |
| Dec-16 | 305.94 | 310.99 | 312.28 | 301.93 |
| Dec-17 | 306.38 | 306.08 | 315.09 | 305.00 |
| Dec-18 | 306.30 | 293.11 | 310.00 | 289.80 |
| Dec-19 | 295.00 | 293.41 | 300.25 | 290.80 |
| Dec-20 | 294.00 | 308.71 | 312.52 | 293.00 |
| Dec-23 | 310.81 | 310.87 | 311.18 | 302.16 |
Madrigal Pharmaceuticals Earnings
Madrigal Pharmaceuticals Earnings Report: Per Share Madrigal Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Madrigal Pharmaceuticals Forecast Revenue Growth
Madrigal Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $4.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.12 per share, and an increase next year of $10.27 per share.
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.